Associated Papers
The IL6/JAK/STAT3 signaling axis is a therapeutic vulnerability in SMARCB1-deficient bladder cancer.
Amara CS et al.
Nature Communications, 2024
38355560 (PubMed )
Supplement: 41467_2024_45132_MOESM4_ESM.xlsx › Sup_Data_1
Integrated proteogenomic characterization of urothelial carcinoma of the bladder.
Xu N et al.
Journal of Hematology & Oncology, 2022
35659036 (PubMed )
Supplement: 13045_2022_1291_MOESM17_ESM.xlsx › Table_S5C
Select a paper to view details